Trajectory and profile of quality of life in patients undergoing lung resection for lung cancer during hospitalization according to the EQ-5D

Author(s):  
Hideo Ichimura ◽  
Keisuke Kobayashi ◽  
Masahiko Gosho ◽  
Kojiro Nakaoka ◽  
Takahiro Yanagihara ◽  
...  
Lung Cancer ◽  
2003 ◽  
Vol 41 ◽  
pp. S292
Author(s):  
Satoshi Hara ◽  
Takeshi Hirohata ◽  
Yukihiko Hashimoto ◽  
Hiroshi Otsuka ◽  
Kenji Minami ◽  
...  

Lung Cancer ◽  
2010 ◽  
Vol 68 (1) ◽  
pp. 115-120 ◽  
Author(s):  
Tobias Schulte ◽  
Bodo Schniewind ◽  
Jessica Walter ◽  
Peter Dohrmann ◽  
Thomas Küchler ◽  
...  

2008 ◽  
Vol 8 (1) ◽  
pp. 79-83 ◽  
Author(s):  
M. Salati ◽  
A. Brunelli ◽  
F. Xiume ◽  
M. Refai ◽  
A. Sabbatini

2013 ◽  
Vol 20 (2) ◽  
pp. e10-e16 ◽  
Author(s):  
Valérie Coats ◽  
François Maltais ◽  
Sébastien Simard ◽  
Éric Fréchette ◽  
Lise Tremblay ◽  
...  

BACKGROUND: Patients with lung cancer often experience a reduction in exercise tolerance, muscle weakness and decreased quality of life. Although the effectiveness of pulmonary rehabilitation programs is well recognized in other forms of cancers and in many pulmonary diseases, few researchers have studied its impact in patients with lung cancer, particularly in those awaiting lung resection surgery (LRS).OBJECTIVES: To investigate the feasibility of a short, home-based exercise training program (HBETP) with patients under investigation for non-small cell lung cancer and potential candidates for LRS, and to determine the effectiveness of this program on exercise tolerance, skeletal muscle strength and quality of life.METHODS: Sixteen patients with lung cancer awaiting LRS participated in a four-week HBETP including moderate aerobic activities (walking and cycling) and muscle training performed three times weekly. Before and after the intervention, a cardiopulmonary exercise test, a 6 min walk test and the assessment of muscle strength and quality of life were performed.RESULTS: Thirteen patients completed the four-week HBETP and all the patients completed >75% of the prescribed exercise sessions. The duration of the cycle endurance test (264±79 s versus 421±241 s; P<0.05) and the 6 min walk test distance (540±98 m versus 568±101 m; P<0.05) were significantly improved. Moreover, the strength of the deltoid, triceps and hamstrings were significantly improved (Δ post-pre training 1.82±2.83 kg, 1.32±1.75 kg and 3.41±3.7 kg; P<0.05, respectively).CONCLUSION: In patients with lung cancer awaiting LRS, HBETP was feasible and improved exercise tolerance and muscle strength. This may be clinically relevant because poor exercise capacity and muscle weakness are predictors of postoperative complications.


2007 ◽  
Vol 125 (1) ◽  
pp. 46-49 ◽  
Author(s):  
Ivete Alonso Bredda Saad ◽  
Neury José Botega ◽  
Ivan Felizardo Contrera Toro

CONTEXT AND OBJECTIVE: There is increasing involvement of health professionals in organizing protocols to determine the impact of lung surgery on functional state and activities of daily living, with the aim of improving quality of life (QoL). The objective of this study was to investigate predictors of QoL improvement among patients undergoing parenchyma resection due to lung cancer. DESIGN AND SETTING: Prospective study, at teaching hospital of Universidade Estadual de Campinas (Unicamp). METHODS: 36 patients with lung cancer diagnosis were assessed before surgery and on the 30th, 90th and 180th days after surgery. The Short-Form Health Survey (SF-36) was used as the dependent variable. The independent variables were the Hospital Anxiety and Depression (HAD) scale, a six-minute walking test (6-MWT), a visual analogue scale for pain, forced vital capacity (FVC), type of surgery and use of radiotherapy and chemotherapy. Generalized estimation equations (GEE) were utilized. RESULTS: The median age for these 20 men and 16 women was 55.5 ± 13.4 years. Both FVC and 6-MWT were predictors of improvement in the physical dimensions of QoL (p = 0.011 and 0.0003, respectively), as was smaller extent of surgical resection (p = 0.04). The social component of QoL had improved by the third postoperative month (p = 0.0005). CONCLUSION: The predictors that affected QoL positively were better FVC and 6-MWT results and less extensive lung resection. Three months after the surgery, an improvement in social life was already seen.


2007 ◽  
Vol 84 (2) ◽  
pp. 410-416 ◽  
Author(s):  
Alessandro Brunelli ◽  
Laura Socci ◽  
Majed Refai ◽  
Michele Salati ◽  
Francesco Xiumé ◽  
...  

2020 ◽  
Vol 07 ◽  
Author(s):  
Deepika Purohit ◽  
Parijat Pandey

Background:: Cancer is one of the significant causes of morbidity and mortality in patients globally. Lung cancer, among other cancers, remains to be one of the principal causes of deaths in both men and women. The most common type of lung cancer is the non-small-cell lung cancer (NSCLC). Apart from lung cancer, pancreatic cancer is also one of the common cancers currently. Objective:: The assessment of QoL in erlotinib-treated patients can also prove to be very useful in the establishment of this drug as the main treatment option for the patients with pancreatic and lung cancer. Methods:: Therapies that target EGFR-mediated signalling are the latest keystones for treating these two types of cancers. They comprise of two main treatment modalities: firstly, against the extracellular fields, that include monoclonal antibodies and secondly, mechanisms that create interferences in the signalling pathways, primarily the small molecule tyrosine kinase inhibitors. Results:: Quality of life (QoL) is one of the key advantages in erlotinib therapy over chemotherapy. Conclusion:: The present review reports the role of erlotinib in improving the quality of life of cancer patients especially in NSCLC and pancreatic cancers. The studies or trials establishing the relations between erlotinib and QoL are discussed in detail in this review.


Sign in / Sign up

Export Citation Format

Share Document